Market Place
Sourcing Support
Artiva Bio Appoints Thad Huston as CFO, Grants Inducement Award
24 Feb 2026 //
GLOBENEWSWIRE
Artiva Bio Appoints Elaine Sorg To Board Of Directors
19 Feb 2026 //
GLOBENEWSWIRE
Artiva Biotherapeutics at 24th Annual Needham Healthcare Conf.
31 Mar 2025 //
GLOBENEWSWIRE
Artiva Biotherapeutics Prices Upsized $167 Million IPO
18 Jul 2024 //
GLOBENEWSWIRE
Actuate unveils modest $50M IPO to fund cancer drug trials
17 Jul 2024 //
FIERCE BIOTECH
Artiva sets out $135M IPO plans to push NK cell therapy through trials
15 Jul 2024 //
FIERCE BIOTECH
Having lost Merck partnership, Artiva looks to IPO to fund NK cell therapy
01 Jul 2024 //
FIERCE BIOTECH
Artiva Readies for Growth: New CFO, COO Appointments
25 Apr 2024 //
BUSINESSWIRE
Artiva Receives FDA Fast Track Designation for AlloNK® in Lupus Nephritis
22 Feb 2024 //
BUSINESSWIRE
Artiva Biotherapeutics Receives Immunology Innovation of the Year in the 2023
08 Nov 2023 //
BUSINESSWIRE
Artiva Biotherapeutics Presents Preclinical Data for AB-101
10 Nov 2022 //
BUSINESSWIRE
Affimed & Artiva Announce Partnership to Combo Therapy of Innate Cell Engager
04 Nov 2022 //
AFFIMED
Artiva Announces Abstract Accepted for Presentation at the 64th ASH
03 Nov 2022 //
BUSINESSWIRE
Artiva Announces AB-101 Abstract Accepted for Presentation at SITC
05 Oct 2022 //
BUSINESSWIRE
Artiva Biotherapeutics Announces FDA Allowance of IND for AB-201
20 Sep 2022 //
BUSINESSWIRE
Artiva Bio Celebrates Official Opening of San Diego Corporate Headquarters
13 Jun 2022 //
BUSINESSWIRE
Artiva Biotherapeutics Appoints Dr. Thorsten Graef as Chief Medical Officer
06 Jun 2022 //
BUSINESSWIRE
Artiva Biotherapeutics Appoints Board of Directors and Clinical Advisory Board
05 May 2022 //
BUSINESSWIRE
Merck extends pact with Artiva; Regeneron-allied biotech pencils in $15M IPO
11 Apr 2022 //
ENDPTS
Artiva Biotherapeutics to Present Preclinical Data for AB-201, a HER2-Targeting
21 Oct 2021 //
BUSINESSWIRE
Artiva Biotherapeutics Demonstrates Commitment, Corporate Social Responsibility
30 Sep 2021 //
BUSINESSWIRE
Merck NK cell ally Artiva splashes out on new digs in San Diego
12 Aug 2021 //
FIERCE BIOTECH
Artiva Biotherapeutics Establishes U.S. Research and Manufacturing Facility
12 Aug 2021 //
BUSINESSWIRE
Artiva to open a manufacturing site to take NK cell operation to the next level
12 Aug 2021 //
ENDPTS
NK cell therapy player Artiva makes some more noise, pulling in $120M Series B
26 Feb 2021 //
ENDPTS
Artiva, fresh from Merck pact, raises $120M for NK therapy R&D
26 Feb 2021 //
FIERCEBIOTECH
With latest deal, Merck wades into cell therapy for cancer
28 Jan 2021 //
BIOPHARMADIVE
Artiva Announces FDA Allowance of IND to Initiate Clinical Trials of AB-101
07 Dec 2020 //
BUSINESSWIRE
Artiva Biotherapeutics Announces FDA Allowance of IND Trials of AB-101
07 Dec 2020 //
BIOSPACE
